“Identifying Novel Protein Biomarkers for Predicting Intravenous Leiomyomatosis Progression and Prognosis Using Data-Independent Acquisition Mass Spectrometry-Based Proteomics”

https://pubmed.ncbi.nlm.nih.gov/38094583

This study used data-independent acquisition mass spectrometry-based proteomics to identify four novel serum protein biomarkers that can predict the progression or prognosis of intravenous leiomyomatosis in the context of predictive, preventive, and personalized medicine.